UPDATE 1-Samsung biopharma unit mulling NASDAQ listing to raise about $1.34 bln

* Samsung Bioepis seen worth 8 trln won market cap-media (Adds Cheil-C&T merger significance, shareholding)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.